Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How could anyone forget the SEC Illegal Judge Fiasco
<<<<<<<< Oh how quickly they forget about that SEC investigation >>>>>>>>
The SEC that knowingly used illegal Judges, that they could hire and fire at will, to achieve a 90% conviction rate.
SEC continued using those unlawful Judges until the Supreme Court told them to stop it, reversing hundreds of SEC Administrative Proceedings decisions including BIEL's.
It looks like KW/IBEX were reinvesting almost all of the proceeds from the sale of converted shares to fund BIEL. In one period mentioned, 1/2010 - 2/2015, IBEX took in $4 million and reinvested $5 million. Due to other sources of financing being unavailable the IBEX loans and reinvestments were essential in keeping the lights on at BIEL.
"Kelly Whelan founded IBEX sometime before 2005 with money raised by taking funds from her personal savings and other sources, with the intention of investing in her father's company, BioElectronics." (page 5)
"Overall, from January 2010 through February 9, 2015, IBEX received approximately $4 million from the Liquidating Entities and sent approximately $5 million to BIEL." (page 7)
It doesn't take a PHD to understand that BIEL will Trade in the low trips until an announcement of significant, revenue producing news
That significant positive event may be in process or may have already occurred but, as we have seen in the past, the PR announcements of events involving partners are controlled by BIEL's partners.
Three Options:
1) Become frustrated waiting on news and Sell
2) Wait for another XX number of days for a positive event knowing BIEL's management loses millions of $$$ if they don't turn the company around, most skin in the game
3) Take out your frustrations with negative posts about BIEL every day on a message board
The number of shares needed to satisfy loan repayment fluctuates with the BIEL Share Price
Loan repayment at a .002 SP takes one tenth the number of shares compared to a .0002 SP.
Sales-Track only shows only one thing
The poster who fraudulently represents Sales-Track as a real company is knowingly presenting false information on the BIEL Board in an effort to damage the company. It is important to remember this deception when reading anything ddls posts.
Twice as many Buys as Sells Today, ----- just sayin
ActiPatch is the Retail product, RecoveryRx is the Medical Professional product having a higher price
That unhinged post speaks volumes about the mental state of the current batch of 'Usual Suspects'
Yeah, it's a real bitch when someone ruins your scam by telling the whole story
More Misleading Information from the Board's Biggest Bozo
<<<<<<< failed to show anything in the FDA Opioid Challenge >>>>>>>
The FDA Opioid Challenge was entered by over 250 companies and there were just 8 companies selected. I will do the math for you, over 242 companies entered and were not selected, some entrants had large company resources like Pfizer who spent $7 billion on R&D in 2018 and was not selected.
Good Grief, Mundiparma's parent company Purdue was shut down
<<<<<<<<<<<<< long list of this company's failures >>>>>>>>>>>>>>>
By all means, BIEL should have foreseen the 2021 BK of Purdue and not signed the 2018 deal with Mundipharma.
Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims
"The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it."
New York Times Published Sept. 1, 2021 Updated Sept. 17, 2021
"Purdue Pharma, the maker of the highly addictive painkiller OxyContin, was dissolved on Wednesday in a wide-ranging bankruptcy settlement that will require the company’s owners, members of the Sackler family, to turn over billions of dollars of their fortune to address the deadly opioid epidemic."
"Judge Robert Drain of the U.S. Bankruptcy Court in White Plains, N.Y., approved the settlement, saying he wanted modest adjustments. The painstakingly negotiated plan will end thousands of lawsuits brought by state and local governments, tribes, hospitals and individuals to address a public health crisis that led to the deaths of more than 500,000 people nationwide."
The MundiPharma Deal was Real, once again suffering from a selective memory
<<<<<<<<<<<<< was MundiPharma real >>>>>>>>>>>>>>>>
Mundipharma had a 'actipatch.au' website and had recruited several Australian pharmacy chains to carry ActiPatch. Mundipharma was part of the Sackler/Purdue empire which was hit with billions of dollars in opioid lawsuits in 2021.
JULY 23, 2018 NEWS, PRESS RELEASES 0 COMMENTS IANWAR@BIELCORP.COM
FREDERICK, MD, July 23, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that Mundipharma Pty Limited (Mundipharma), https://www.mundipharma.com.au/ has added ActiPatch® to its pain management portfolio, by acquiring the exclusive Australian and New Zealand distribution rights to the ActiPatch® Musculoskeletal Pain Therapy medical device.
“The addition of ActiPatch® to our existing pain medications confirms our commitment to help clinicians manage pain with a multimodal approach, including non-drug therapies. Our education programs for healthcare professionals emphasize the importance of stepped multimodal pain management, so I’m delighted that we’re now able to offer ActiPatch®,” said Jane Orr, Managing Director of Mundipharma Australia and New Zealand.
Thanks toohot, The picture on your link looks like it could be the newly redesigned ActiPatch
Notice there are no chips or electrical connections visible through a clear resin, the entire face is now white and the green light has been moved.
2/15/2024 Update
"The Company, working with its Chinese manufacturer, recently redesigned the manufacturing process to increase the reliability and shelf life of its current OTC product."
With BIEL conserving resources in most all areas in 2023 would they spend $272k on R&D, including the redesign of ActiPatch, if they did not feel it was needed to close a deal?
Definitely been hanging with Art if you won't admit the significant difference between a 5% success rate versus a 25% success rate.
You are casting too wide of a net, when specifying 'Medical Device Companies' the failure rate is 75%
<<<<<<<< 19 of 20 biotechs fail. >>>>>>>>
"In the US, 75% of medical device start-ups fail, and 98% of digital health startups fail. Moreover, 75% of venture-backed companies never return cash to their investors, and in 30-40% of cases, investors lose their entire initial investment. Oct 25, 2023
When looking at failure rates of all Startup businesses combined the rate is 90%.
"The average cost to bring a 510(k) product from concept to market exceeds $31 million, with greater than 77% of the cost—approximately $24 million— spent on regulatory and FDA-related activities. The cost of a PMA averages $94 million, with $75 million spent on FDA-linked stages. That is nearly 80% of the total amount."
BIEL does not have just 1 FDA 510k Indication but 5 :
Blepharoplasty (eyelid surgery) K022404
Postoperative Pain K190251
Plantar Fasciitis K152432 (OTC)
Knee Osteoarthritis K152432 (OTC)
Musculoskeletal Pain K192234 (OTC)
Some have a very selective memory, must be how we end up with so many opinions and opinions only
4/26, Buys 21.7 million shares, Sells 6.1 million shares
Apparently the Usual Suspects don't follow companies that have suffered setbacks and then bounce back
Here is one that I have personal experience with, Sirius XM.
Sirius which had a SP in the $50 - $60 range in the early 2000s saw their SP drop to $4 in 2002. Getting their platform established and competing with XM was draining their resources. Sirius merged with XM in 2008 but the Sub Prime Mortgage Crisis had caused a recession and badly damaged new car sales, their primary source of new customers.
Sirius XM tried to get bank loans but there were none willing to take that risk during a recession. Liberty Media's John Malone came to Sirius XM's rescue with a $530 million loan but it Cost Sirius XM 40% of the company. The SP bottomed out at 5 cents in 2/2009. I noticed Sirius XM in 4/2009 and started buying at 32 cents.
Liberty Media purchased another 10% in 2013 to take control of Sirius XM. I sold shortly after this change of control in the low $3 range.
Companies do come back from adversity, despite those that will tell anyone willing to listen that they are finished.
Buy/Sell ratio is much more useful than your '6 trades with .0001 on the Bid' BS
Another 16.4 million shares Shorted today with 483 million shares on the Bid Size and 157 million shares on the Ask Size.
Date ..... Symbol .. Short vol .. Total vol
20240426 | BIEL | 16485000 | 28245000
From the UCSD statements on the Postoperative Analgesia Study
"Study intervention. The pulsed shortwave device (2 devices, if there are multiple incisions or the incision is larger than the device diameter; 3 devices for total knee and hip arthroplasty or spinal surgery) will be affixed over the primary wound area(s) using tape and activated prior to recovery room discharge (Experimental). The optimal location to treat phantom pain is currently unknown and will partially informed by the results of this pilot study, and patients will be encouraged to move the devices to a new anatomic location until relief is optimized."
"Specific Aim 2: To estimate the treatment effect of adding nonthermal, pulsed shortwave therapy to usual and customary analgesia on pain and opioid consumption following moderate-to-severely painful surgical procedures."
"Hypothesis 2: Nonthermal, pulsed shortwave therapy decreases opioid use in the 7 days following moderate-to-severely painful surgical procedures."
"The two outcomes of primary interest will be (1) the "average" and "worst" pain measured with the Numeric Rating Scale (included in the Brief Pain Inventory pain domain), and (2) opioid consumption within the first 7 postoperative days."
"Treatment with BioElectronics Model 088"
"Status - in progress, not accepting new patients
Start Date - July 2022
Completion Date - April 3, 2024 (estimated)
Sponsor - University of California, San Diego
ID - NCT05399355
Study Type - Interventional
Participants - About 120 people participating
Last Updated - February 8, 2024"
https://clinicaltrials.ucbraid.org/trial/NCT05399355
A more accurate April 26 view, Buys @ 2 Outnumber Sells @ 1 by a 3 to 1 Margin
Buys = 21.7 million shares
Sells = 6.1 million shares
Neutral = 407k shares
Closing SP = .00015
This will help you understand the system
<<<<<< Funny, that stock didn't materialize out of thin air >>>>>>
Counterfeiting Stock 2.0
Illegal naked shorting and stock manipulation are two of Wall Street’s deep, dark secrets.
These practices have been around for decades and have resulted in trillions of dollars being
fleeced from the American public by Wall Street. In the process, many emerging companies have
been put out of business. This report will explain the magnitude of this problem, how it happens,
why it has been covered up and how short sellers attack a company. It will also show how all of
the participants; the short hedge funds, the prime brokers and the Depository Trust Clearing
Corp. (DTCC) - make unconscionable profits while the fleecing of the small American investor
continues unabated.
Why is This Important? This problem affects the investing public. Whether invested directly in
the stock market or in mutual funds, IRAs, retirement or pension plans that hold stock – it
touches the majority of Americans.
The participants in this fraud, which, when fully exposed, will make Enron look like child’s
play, have been very successful in maintaining a veil of secrecy and impenetrability. Congress
and the SEC have unknowingly (?) helped keep the closet door closed. The public rarely knows
when its pocket is being picked as unexplained drops in stock price get chalked up to “market
forces” when they are often market manipulations.
The stocks most frequently targeted are those of emerging companies who went to the stock
market to raise start-up capital. Small business brings the vast majority of innovative new ideas
and products to market and creates the majority of new jobs in the United States. It is estimated
that over 1000 of these emerging companies have been put into bankruptcy or had their stock
driven to pennies by predatory short sellers.
It is important to understand that selling a stock short is not an investment in American
enterprise. A short seller makes money when the stock price goes down and that money comes
solely from investors who have purchased the company’s stock. A successful short manipulation
takes money from investment in American enterprise and diverts it to feed Wall Street’s
insatiable greed - the company that was attacked is worse off and the investing public has lost
money. Frequently this profit is diverted to off-shore tax havens and no taxes are paid. This
national disgrace is a parasite on the greatest capital market in the world.
10. Fails-to-Deliver – The process of creating shares via naked shorting creates an obvious
imbalance in the market as the sell side is artificially increased with naked short shares or
more accurately, counterfeit shares. Time limits are imposed that dictate how long the
sold share can be naked. For a stock market investor or trader, that time limit is three
days. According to SEC rules, if the broker dealer has not located a share to borrow, they
are supposed to take cash in the short account and purchase a share in the open market.
This is called a “buy-in,” and it is supposed to maintain the total number of shares in the
market place equal to the number of shares the company has issued.
Market makers have special exemptions from the rules: they are allowed to carry a
naked short for up to twenty-one trading days before they have to borrow a share. When
the share is not borrowed in the allotted time and a buy-in does not occur, and they rarely
do, the naked short becomes a fail-to-deliver (of the borrowed share).
The Creation of Counterfeit Shares – There are a variety of names that the securities industry
has dreamed up that are euphemisms for counterfeit shares. Don’t be fooled: Unless the short
seller has actually borrowed a real share from the account of a long investor, the short sale is
counterfeit. It doesn’t matter what you call it and it may become non-counterfeit if a share is later
borrowed, but until then, there are more shares in the system than the company has sold.
The magnitude of the counterfeiting is hundreds of millions of shares every day, and it may
be in the billions. The real answer is locked within the prime brokers and the DTC. Incidentally,
counterfeiting of securities is as illegal as counterfeiting currency, but because it is all done
electronically, has other identifiers and industry rules and practices, i.e. naked shorts, fails-todeliver, SHO exempt, etc. the industry and the regulators pretend it isn’t counterfeiting. Also,
because of the regulations that govern the securities, certain counterfeiting falls within the letter
of the rules. The rules, by design, are fraught with loopholes and decidedly short on allowing
companies and investors access to information about manipulations of their stock.
https://www.sec.gov/comments/s7-07-23/s70723-20162302-331156.pdf
Every Year, Like a Broken Record
"BIEL is finished"
"No way BIEL survives SEC"
"No way BIEL gets FDA Reclassification"
"No way BIEL gets Plantar Fasciitis Clearance"
"No way BIEL gets Knee Osteoarthritis Clearance"
"No way BIEL gets OTC Clearance"
"No way BIEL gets CE Mark"
"No way BIEL gets Musculoskeletal Clearance"
"No way BIEL gets Post-Op Pain Clearance"
"Andy told me BK coming"
"Andy told me RS coming"
Always Wrong
If you are citing the OTC Markets Cromwell Coulson article, he is the President, CEO, and Director of the OTC Markets. His job is to make investors comfortable with the OTC so that they will spend more money. He is not going to tell you how many times Market Makers have been caught abusing their power / violating Shorting Regulations and that many times the violations go on for years and years before they are caught if they are ever caught.
SEC Charges Citadel Securities for Violating Order Marking Requirements of Short Sale Regulations
Washington D.C., Sept. 22, 2023 —
The Securities and Exchange Commission today announced settled charges against broker-dealer Citadel Securities LLC for violating a provision of Regulation SHO, the regulatory framework designed to address abusive short selling practices, which requires broker-dealers to mark sale orders as long, short, or short exempt. These records are routinely used by regulators in policing prohibited short selling activity. To settle the SEC’s charges, Miami-based Citadel Securities agreed to pay a $7 million penalty. According to the SEC’s order, for a five-year period, it is estimated that Citadel Securities incorrectly marked millions of orders
“Compliance with the order marking requirements of Reg SHO is a key component of regulatory efforts to curtail abusive market practices, including ‘naked’ short selling,” said Mark Cave, Associate Director of the SEC’s Division of Enforcement.
Goldman Sachs fined $3M by FINRA over mismarked short sales
Wed, Apr 5, 2023 10:36 AM
Goldman Sachs was fined $3 million by the Financial Industry Regulatory Authority (FINRA) for mismarking nearly 60 million short sell orders as long and related supervision failures. From 2015-18, Goldman Sachs’s automated trading software mismarked sell orders following a system upgrade intended to simplify order flow, according to FINRA.
Merrill to Pay $850K FINRA Fine Over Short Sale Violations
October 07, 2021 at 02:37 PM
Merrill misapplied the SEC-approved Multi-day Approach on at least 6,000 occasions, FINRA alleged. From September 2013 until July 2016, Merrill violated Rule 204 of Regulation SHO and FINRA Rule 2010. Also, from January 2005 until January 2015, Merrill violated Rule 200(f) of Regulation SHO.
Absolutely, MMs are dumping shares they don't own, 44.4 million shares Shorted today
<<<<<<< More dumping today, 48,067,000 shares >>>>>>>
Less than 12,000 shares were sold today by the actual owners of those shares.
FINRA Reg SHO Daily Short Report
Date ... Symbol .. Short vol ... Total vol
20240424 | BIEL | 44480000 | 56127000
Retail Traders can not enter a 5 digit to the right of the decimal point order.
However, five digit executed orders do turn up frequently by way of MMs filling an order placed at the Ask Price at a lower price.
Today's five digit fills were entered at the Ask of .0002 and filled at .00014 & .00015 .
Yesterday's closing order for 100,000 shares, along with several others, was entered at a .0002 SP but filled at .00015 .
What a load of nonsense
<<<<< inept management team continues to unload shares on an unsuspecting public >>>>>
Per the 2023 Financials:
KW only owns 37 million shares.
RS owns Zero shares.
KN only owns 100 million shares.
BIEL only has 295 million shares available in their Authorized Shares and they do not sell shares directly into the Market.
"STOP PRETENDING" is what I say every time a statistic from phony 'Sales Track' flows out of your libelous cakehole
Actually 279 million shares were Sells, 6 million Buys, but 191 million shares were Shorted
Date ..... Symbol .. Short vol ... Total vol
20240423 | BIEL | 191987615 | 285678650
It's hard to crow about a "300 million share sell-off" when the MMs sold 191 million shares that they did not own.
Somewhere between 88 and 94 million shares were sold at 1 today by shareholders who actually owned the shares that they sold.
The spike in 2021 is no mystery
BIEL signed the KT Tape deal in 2020. Q4 of 2020 saw 9500 lbs of the KT Wave shipped to KT.
Q2 of 2021 saw 2 shipments to KT totaling 19,000 lbs of the Wave.
BIEL lived up to their end of the contract, suppling all of the Wave devices that KT ordered.
KT failed to aggressively market the Wave. They priced it $5 higher than ActiPatch, $34.95, and reduced the hours of use from 720 to 250. Existing ActiPatch customers said, 'No Thanks'. KT chose to stay in their comfort zone with the athlete/weekend warrior market when the chronic pain market was many times larger.
The Assisi Loop is the animal version of the Endonovo Sofpulse
They use the same 27.12 MHz signal as the ActiPatch but there are several differences.
Assisi/Sofpulse uses 2 of the 2032 3 volt batteries where the ActiPatch uses one.
Assisi/Sofpulse is said to have an 8 day continuous use life span while ActiPatch has a 30 day continuous use life.
Assisi/Sofpulse is made to deliver therapy in sessions of 15-30 minutes with 2 hour gaps between sessions while the ActiPatch delivers a constant, lower powered therapy.
The pulse rate is all so different between the devices.
Further confirmation of efficacy by 2 Universities & 1 Hospital in Rome
Current Evidence Using Pulsed Electromagnetic Fields in Osteoarthritis
Published: 28 March 2024
(1) Background: Osteoarthritis (OA) significantly impacts patients’ quality of life and negatively affects public healthcare costs. The aim of this systematic review is to identify the effectiveness of pulsed electromagnetic fields (PEMFs) in OA treatment across different anatomical districts, determining pain reduction and overall improvement in the patient’s quality of life. (3) Results: PEMF therapy demonstrated positive outcomes across various anatomical districts, primarily in knee osteoarthritis. Pain reduction, assessed through VAS and WOMAC scores, showed significant improvement (60% decrease in VAS, 42% improvement in WOMAC). The treatment duration varied (15 to 90 days), with diverse PEMF devices used. Secondary outcomes included improvements in quality of life, reduced medication usage, and enhanced physical function.
3.2. Type of PEMF Device
These studies investigated the utilization of both presently available PEMF devices on the market and outdated, no longer used equipment. The variety of PEMF devices employed in these studies introduced an additional layer of complexity to the analysis. [Table 2]. Devices such as those from the Bioelectronics Corporation (BioElectronics Corporation- Metropolitan Court Fredrick, MD, USA), Magcell Arthro (Physiomed Elektromedizin-Hutweide, Schnaittach, Germany), and XT-2000 B by the Better Health Corporation (Abbotsford, Victoria, Australia), each characterized by unique specifications like the frequency and intensity of the magnetic field, highlight the technological variability within PEMF therapy. For instance, the Bioelectronics Corporation’s device has a carrier frequency of 27.12 MHz and emits 1000 pulses per second.
4.4. Outcomes and Result Heterogeneity
The consistent focus on pain reduction as a primary outcome, measured using visual analog scales or disease-specific scales, indicates positive trends in PEMFs’ analgesic effects. Diverse secondary outcomes, including quality of life assessments, changes in analgesic and NSAID intake, and improvements in physical function, reflect the multifaceted impact of PEMF therapy on osteoarthritis.
https://www.mdpi.com/2077-0383/13/7/1959
"STOP PRETENDING" says the guy who quotes statistics from the nonexistent Sales Track,
and has to have a disclaimer on all posts to remind people that he deals in "Opinion Only", no pesky facts to worry about.
"Everything I say and write is my opinion and my opinion only."
Ya botched quoting a 13 word sentence
"Anyone with half a brain can see that this was a planned effort."
<<<<<<< So what was the plan? >>>>>>>
Anyone with half a brain has figured it out.
LOL, It was a dump of 23 million shares 1 minute before the Close
All day long the Trades were at .0002, .00025, and .0003, Zero 1s on the Bid and Zero 1s Traded.
At 3:58:51 someone takes out the 1.3 million shares on the 2 Bid.
At 3:59:04, 22 million shares are dumped into the .0001 Bid which has 448 million shares available and the Market closes 56 seconds later.
Anyone with half a brain can see that this was a planned effort.
There is at least one step BIEL has advised shareholders of
<<<<< I want to know what concrete steps the company is taking to take advantage of the change in law >>>>>
2/15/2024 Chairman Update
"The Company also did a proof-of-concept production run of its newly designed RecoveryRx product that is 50% more powerful and has a larger antenna thereby increasing the size of the surgical incision that can be treated. The plan is to test market these devices in the near future."
A 50% increase in power means more pain relief, and faster pain relief. This further reduces the amount of pain relief drugs a surgical patient requires.
2023 Financials
KW foregoes all salary for years ending December 31, 2023 / 2022
IBEX LLC agreed to forgo all interest from 2020 through 2023
Keith Nalepka still owns 100 million BIEL Shares
Dr Staelin supports BIEL with $500k in new loans for 2023
BIEL still investing in R&D $272K
Revenue up from 2022
General/Administrative costs down by $80k compared to 2022
Sales/Marketing cost lowered by $120k compared to 2022
Basic deduction, any substantial sales in Q2, 3 or 4 of 2023 would have been announced by BIEL
Subjects for possible news in Update:
* Further news on the redesigned ActiPatch
* Further news on the new RecoveryRx with a 50% power increase
* Further news on the major distributor talks, final approval
* Further news on the $14 million breach of contract lawsuit against Mundipharma
* Further news on the US direct to consumer sales with "Money Back Guaranty"
* Further news on the Veterinarian market/ Vagus nerve stimulation
* News in areas not previously disclosed
Financials have usually been released after the Market closes
IMO, the numbers from 2023 will not be the thing to focus on. Hopefully an Update will be released shortly after the Financials with information on progress made in 2024.
Regarding yourself that question has been answered, Revenge
<<<<<<<< "Why do you even bother, spending so much time on this?" >>>>>>>>
A former BIEL employee, 'Terminated for Cause', becomes obsessed with destroying his former employer.
Yes, who in their right mind would want to enter the pet market
86 million US households have pets
$136 billion spent on pets in 2023 in US
$235 billion spent world wide on pets